# Reveal LINQ™ Evaluation of Fluid

> **NCT02275923** · NA · TERMINATED · sponsor: **Medtronic Cardiac Rhythm and Heart Failure** · enrollment: 9 (actual)

## Conditions studied

- End Stage Renal Disease

## Interventions

- **DEVICE:** Reveal LINQ™ Insertable Cardiac Monitor

## Key facts

- **NCT ID:** NCT02275923
- **Lead sponsor:** Medtronic Cardiac Rhythm and Heart Failure
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-10
- **Primary completion:** 2015-07
- **Final completion:** 2015-07
- **Target enrollment:** 9 (ACTUAL)
- **Why stopped:** Study terminated as sufficient data was collected to determine if impedance measurements with the LINQ™ device could track body fluid changes.
- **Last updated:** 2019-04-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02275923

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02275923, "Reveal LINQ™ Evaluation of Fluid". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02275923. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*